Variant report

Variant	nsv833392
Chromosome Location	chr2:11054580-11235239
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:160)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:160 , 50 per page) page: 1 2 3 4

No.	Distal block	Cell Line	Cell type
1	chr2:11063866..11066911-chr2:11073875..11076596,3	K562	blood:
2	chr2:11127447..11130208-chr2:11164177..11166978,2	K562	blood:
3	chr2:11127447..11130208-chr2:11164177..11166978,2	K562	blood:
4	chr2:11074723..11077921-chr2:11081034..11085033,4	MCF-7	breast:
5	chr2:11165889..11168085-chr2:11176369..11179284,2	K562	blood:
6	chr2:11051784..11053608-chr2:11064157..11066409,2	MCF-7	breast:
7	chr2:11213126..11213688-chr2:11263390..11264093,2	MCF-7	breast:
8	chr2:11079423..11082199-chr2:11261884..11263579,2	MCF-7	breast:
9	chr2:11133150..11133773-chr2:11270117..11270743,2	MCF-7	breast:
10	chr2:11049420..11051539-chr2:11073823..11076217,2	MCF-7	breast:
11	chr2:11054784..11057728-chr2:11061728..11064590,3	MCF-7	breast:
12	chr2:11129287..11130946-chr2:11134208..11136297,2	K562	blood:
13	chr2:11111924..11114529-chr2:11115267..11117475,2	K562	blood:
14	chr2:11056290..11057062-chr2:11066095..11066758,2	K562	blood:
15	chr2:11075163..11076703-chr2:11081992..11083807,2	K562	blood:
16	chr2:11192659..11195010-chr2:11197326..11199050,2	K562	blood:
17	chr2:11084869..11086580-chr2:11100283..11102458,2	MCF-7	breast:
18	chr2:11065411..11067104-chr2:11075096..11077076,2	K562	blood:
19	chr2:11192261..11193853-chr2:11219534..11222472,2	MCF-7	breast:
20	chr2:11050815..11054618-chr2:11074174..11077815,3	MCF-7	breast:
21	chr2:11074952..11076639-chr2:11264485..11265994,2	MCF-7	breast:
22	chr2:11217637..11219287-chr2:11222493..11224652,2	MCF-7	breast:
23	chr2:11070868..11073523-chr2:11073573..11076580,4	MCF-7	breast:
24	chr2:11101663..11103328-chr2:11105631..11107233,2	K562	blood:
25	chr2:11049134..11051684-chr2:11064717..11067313,2	K562	blood:
26	chr2:11221296..11223219-chr2:11223373..11224955,2	MCF-7	breast:
27	chr2:11049867..11053292-chr2:11184248..11187361,3	MCF-7	breast:
28	chr2:11125108..11127866-chr2:11128191..11131887,3	MCF-7	breast:
29	chr2:11142511..11144032-chr2:11147175..11149788,2	MCF-7	breast:
30	chr13:111107958..111109838-chr2:11209436..11210956,2	MCF-7	breast:
31	chr2:11224082..11226359-chr2:11231709..11234438,2	MCF-7	breast:
32	chr2:11129287..11130946-chr2:11134208..11136297,2	K562	blood:
33	chr2:11100622..11103209-chr2:11103997..11106822,4	MCF-7	breast:
34	chr2:11105980..11108837-chr2:11120385..11122053,2	K562	blood:
35	chr2:11051577..11052466-chr2:11168267..11169232,6	MCF-7	breast:
36	chr2:11125762..11128008-chr2:11133309..11135944,2	MCF-7	breast:
37	chr2:11213696..11215266-chr2:11216231..11217770,2	MCF-7	breast:
38	chr2:11065411..11067104-chr2:11075096..11077076,2	K562	blood:
39	chr2:11165889..11168085-chr2:11176369..11179284,2	K562	blood:
40	chr2:11161870..11163474-chr2:11165719..11167613,2	MCF-7	breast:
41	chr2:11105110..11107572-chr2:11111970..11114235,2	MCF-7	breast:
42	chr2:11074983..11076503-chr2:11504797..11506450,2	MCF-7	breast:
43	chr2:11106660..11108863-chr2:11115845..11117548,2	MCF-7	breast:
44	chr2:11192467..11195244-chr2:11216881..11219643,2	MCF-7	breast:
45	chr2:11054784..11057728-chr2:11061728..11064590,3	MCF-7	breast:
46	chr2:11213310..11214023-chr2:11269749..11271029,3	MCF-7	breast:
47	chr2:11207479..11209731-chr2:11210577..11212814,2	K562	blood:
48	chr2:11158514..11161172-chr2:11207047..11208600,2	MCF-7	breast:
49	chr2:11053991..11056052-chr2:11065201..11067671,2	MCF-7	breast:
50	chr2:11054479..11055033-chr2:11168295..11169158,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KCNF1-1	chr2:11075634-11075980	NONHSAT069134
2	lnc-ROCK2-8	chr2:11157371-11157639	ucscGeneNc_uc002ray_1
3	lnc-ROCK2-8	chr2:11156577-11157234	ucscGeneNc_uc002ray_1

No data

Variant related genes	Relation type
ENSG00000134318	chromatin interactions
ENSG00000162975	chromatin interactions
ENSG00000230952	chromatin interactions

Extended variants
information (count: 6367 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:6367 , 50 per page) page: 1 2 3 4 5 6 7 ... 128

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs541263475	chr2:11054599-11054600	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
2	rs559792878	chr2:11054607-11054608	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
3	rs527414457	chr2:11054610-11054611	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
4	rs555612799	chr2:11054627-11054628	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
5	rs545746962	chr2:11054656-11054657	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs563934187	chr2:11054658-11054659	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
7	rs565751637	chr2:11054660-11054661	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
8	rs531586635	chr2:11054663-11054664	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
9	rs183117756	chr2:11054707-11054708	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
10	rs549409531	chr2:11054714-11054715	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
11	rs369456294	chr2:11054737-11054738	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
12	rs144567073	chr2:11054756-11054757	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
13	rs571521671	chr2:11054772-11054773	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
14	rs371360461	chr2:11054777-11054778	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
15	rs187768377	chr2:11054783-11054784	Bivalent Enhancer Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
16	rs557835283	chr2:11054819-11054820	Bivalent Enhancer Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
17	rs111310780	chr2:11054827-11054828	Bivalent Enhancer Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
18	rs566144626	chr2:11054855-11054856	Bivalent Enhancer Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
19	rs11901805	chr2:11054858-11054859	Bivalent Enhancer Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs147249526	chr2:11054938-11054939	Bivalent Enhancer Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
21	rs192518834	chr2:11054994-11054995	Bivalent Enhancer Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
22	rs569951264	chr2:11054995-11054996	Bivalent Enhancer Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
23	rs537496125	chr2:11055032-11055033	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs141681214	chr2:11055034-11055035	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs184076989	chr2:11055057-11055058	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs556061873	chr2:11055117-11055118	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs576155680	chr2:11055120-11055121	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs567761069	chr2:11055134-11055135	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs187821095	chr2:11055138-11055139	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs192449771	chr2:11055159-11055160	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs114313512	chr2:11055160-11055161	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs527285180	chr2:11055234-11055235	Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs572064343	chr2:11055237-11055238	Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs533163053	chr2:11055245-11055246	Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs564252962	chr2:11055278-11055279	Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs17365678	chr2:11055298-11055299	Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs543476576	chr2:11055323-11055324	Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs12623956	chr2:11055328-11055329	Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs529220742	chr2:11055383-11055384	Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs547575045	chr2:11055446-11055447	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs559287285	chr2:11055471-11055472	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs533203721	chr2:11055507-11055508	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs2123483	chr2:11055557-11055558	Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs570168531	chr2:11055611-11055612	Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs537028222	chr2:11055625-11055626	Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs59786077	chr2:11055636-11055637	Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs184800408	chr2:11055637-11055638	Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs148058253	chr2:11055645-11055646	Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs61193809	chr2:11055652-11055653	Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs553100942	chr2:11055670-11055671	Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Mental retardation	17847001	CNVD
Glioblastoma multiforme	21080181	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Cancer	20164920	CNVD
Neuroblastoma	21508638	CNVD
Breast cancer	17603634	CNVD
Cancer	16751803	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Ependymoma	16718352	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Bladder cancer	21909424	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Glioma	17123091	CNVD
Breast cancer	20409316	CNVD
Multiple myeloma	16616336	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Melanoma	20877625	CNVD

Chromatin state (count:1348 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:11051200-11054600	Bivalent Enhancer	Placenta	Placenta
2	chr2:11051600-11054600	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
3	chr2:11051600-11056200	Active TSS	Brain Angular Gyrus	brain
4	chr2:11052200-11054600	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr2:11052600-11054600	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
6	chr2:11052800-11054800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
7	chr2:11052800-11055400	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
8	chr2:11053600-11054600	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
9	chr2:11053600-11054600	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
10	chr2:11053600-11054800	Active TSS	Brain Cingulate Gyrus	brain
11	chr2:11053600-11054800	Flanking Active TSS	Fetal Brain Female	brain
12	chr2:11053600-11058200	Enhancers	Fetal Brain Male	brain
13	chr2:11053600-11058800	Weak transcription	Pancreas	Pancrea
14	chr2:11053800-11054600	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
15	chr2:11053800-11054600	Enhancers	Right Ventricle	heart
16	chr2:11053800-11054800	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
17	chr2:11053800-11054800	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
18	chr2:11053800-11055200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr2:11053800-11056000	Active TSS	Pancreatic Islets	Pancreatic Islet
20	chr2:11053800-11058800	Weak transcription	Gastric	stomach
21	chr2:11054000-11054600	Bivalent Enhancer	Fetal Heart	heart
22	chr2:11054000-11054600	Bivalent Enhancer	Left Ventricle	heart
23	chr2:11054000-11056600	Active TSS	Brain Anterior Caudate	brain
24	chr2:11054200-11054600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr2:11054200-11054600	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
26	chr2:11054200-11054600	Flanking Active TSS	A549	lung
27	chr2:11054200-11054800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
28	chr2:11054200-11054800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
29	chr2:11054200-11055000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
30	chr2:11054200-11055000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
31	chr2:11054200-11055600	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
32	chr2:11054200-11056400	Active TSS	Brain Germinal Matrix	brain
33	chr2:11054200-11063600	Enhancers	Fetal Thymus	thymus
34	chr2:11054400-11054600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
35	chr2:11054400-11054600	Bivalent Enhancer	Duodenum Mucosa	Duodenum
36	chr2:11054400-11054600	Flanking Bivalent TSS/Enh	Rectal Smooth Muscle	rectum
37	chr2:11054400-11054600	Active TSS	Hela-S3	cervix
38	chr2:11054400-11055000	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
39	chr2:11054400-11055400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
40	chr2:11054400-11072400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
41	chr2:11054600-11054800	Enhancers	iPS-18 Cell Line	embryonic stem cell
42	chr2:11054600-11054800	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
43	chr2:11054600-11054800	Bivalent Enhancer	HepG2	liver
44	chr2:11054600-11055000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
45	chr2:11054600-11055000	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
46	chr2:11054600-11055000	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
47	chr2:11054600-11055000	Flanking Bivalent TSS/Enh	Stomach Smooth Muscle	stomach
48	chr2:11054600-11055200	Bivalent/Poised TSS	Fetal Muscle Trunk	muscle
49	chr2:11054600-11055200	Enhancers	A549	lung
50	chr2:11054600-11055400	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links